Early recurrence after surgery in FIGO 2023 stage I-III endometrial cancer: characteristics and risk factors
BackgroundUnderstanding the risk factors for early recurrence is crucial for improving endometrial cancer (EC) patient outcomes.MethodsWe conducted a retrospective analysis of clinicopathological data from 473 patients diagnosed with EC at the First Affiliated Hospital of Chongqing Medical Universit...
Saved in:
Main Authors: | Zhen Huang, Xue Li, Ling Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1500658/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma
by: Anuja Yadav, et al.
Published: (2023-07-01) -
FIGO 2023 staging system predicts not only survival outcome but also recurrence pattern in corpus-confined endometrial cancer patients
by: Hua-Hsi Wu, et al.
Published: (2025-01-01) -
A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
by: Bohao Zhang, et al.
Published: (2025-01-01) -
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery
by: Tomoka Maehana, et al.
Published: (2024-12-01) -
Rationality of the FIGO2023 staging for early-stage endometrial cancer, compared with the FIGO2009 staging
by: Yiqin Wang, et al.
Published: (2024-04-01)